However, these differences did not reach statistical significance, potentially due to a high placebo response and other contributing factors.
← all excerpts
Efficacy and safety of GW117 tablets in major depressive disorder: a randomised, double-blind, placebo-controlled, phase 2 dose-finding study.
1
—
—